Skip to main content
Equibles

RHUMBLINE ADVISERS

Position in BCYC — Bicycle Therapeutics PLC

CIK 1115418 BOSTON, MA
Back to BCYC Full portfolio

Position in BCYC

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$67,700
+$9,371 QoQ
Shares Held
15,967
+27.0% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#64
of 103 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BCYC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. BCYC ranks #287 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 396,380 $196,893,837
2 REGN
Regeneron Pharmaceuticals, Inc.
 157,794 $98,390,870
3 MRNA
Moderna, Inc.
 809,853 $56,714,005
4 ALNY
Alnylam Pharmaceuticals, Inc.
 165,579 $49,844,246
5 INCY
Incyte Corp
 428,533 $48,578,500
6 RVMD
Revolution Medicines, Inc.
 226,008 $42,326,778
7 ROIV
Roivant Sciences Ltd.
 1,178,789 $41,717,342
8 JAZZ
Jazz Pharmaceuticals plc
 163,018 $39,282,447

All Filings in BCYC

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $67,700 15,967
2026-03-31 $58,329 12,571
2025-12-31 $79,090 11,171
2025-09-30 $25,348 3,275
2025-06-30 $20,884 3,005
2025-03-31 $11,070 1,304
2024-12-31 $16,198 1,157
2024-09-30 $24,893 1,100
2024-06-30 $20,786 1,027
2024-03-31 $15,911 639
2023-12-31 $7,412 410
2023-09-30 $8,236 410
2023-06-30 $9,697 380